Cerebral embolism caused by a left cardiac ventricle metastatic tumor
Neurol 69:407-408, Yagita, Y.,et al, 2007
Paraneoplastic Vasculitis of Central Nervous System Presenting as Recurrent Cryptogenic Stroke
Int J Clin Oncol 12:155-159, Taccone,F.S.,et al, 2007
Classical Disease Revisited: Transient Global Amnesia
Postgrad Med 83:236-239, Owen, D.,et al, 2007
Behcets Disease Presented with Isolated Peduncular Hallucinosis: A Case Report
Internet J Neurol 9, Celik, Y.,et al, 2007
Stroke as the First Manifestation of Concealed Cancer
J Neurol Sci 258:80-83, Kwon, H.M.,et al, 2007
"Salt and Pepper" in the Eye and Face: A Prelude to Brainstem Ischemia
Am J Ophthalmol 144:322-325, Conforto, A.B.,et al, 2007
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Wolff-Parkinson-White Syndrome in Patients with MELAS
Arch Neurol 64:1625-1627, Sproule,D.M.,et al, 2007
Prevention of Menstrual Attacks of Migraine: A Double-Blind Placebo-Controlled Crossover Study
Neurol 67:2159-2163, MacGregor,E.A.,et al, 2006
Trends in Incidence, Lifetime Risk, Severity, and 30-Day Mortality of Stroke Over the Past 50 Years
JAMA 296:2939-2946, Carandang,R.,et al, 2006
Vascular Parkinsonism and Dementia in a CADASIL Case with Intact Nigrostriatal Dopaminergic System
Akt Neurol 33: Suppl, Wegner,F.,et al, 2006
Small Vessels, Big Problems
NEJM 354:1451-1453, Greenberg,S.M., 2006
Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006
The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke
Stroke 37:1120-1122, Soman,T.,et al, 2006
Influence of Metabolic Syndrome and General Obesity on the Risk of Ischemic Stroke
Stroke 37:1060-1064, Chen,H.-J.,et al, 2006
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Nonaneurysmal Convexity Subarachnoid Hemorrhage
Neurocrit Care 4:229-233, Patel,K.C. &Finelli,P.F., 2006
Ischemic Strokes After Cardiac Catheterization
Arch Neurol 63:817-821, Khatri,P. &Kasner,S.E., 2006
Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
Stroke 37:1822-1827, Audebert,H.,et al, 2006
Hyperbaric Oxygen Therapy for Acute Ischemic Stroke
Stroke 37:1953-1954, Bennett,M.H.,et al, 2006
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Stroke 37:1715-1719,1637, Hays,A.G.,et al, 2006
Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006
Perforator Stroke After Elective Stenting of Symptomatic Intracranial Stenosis
Neurol 66:1868-1872,1803, Jiang,W.,et al, 2006
The Thalamus and Behavior. Effects of Anatomically Distinct Strokes
Neurol 66:1817-1823, Carrera,E. &Bogousslavsky,., 2006
Door to Thrombolysis: ER Reorganization and Reduced Delays to Acute Stroke Treatment
Neurol 67:334-336, Lindsberg,P.J.,et al, 2006
Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke
Stroke 37:2168-2169, Wiese,K.M.,et al, 2006
Recurrent Extracranial Carotid Artery Vasospasms. Report of 2 Cases
Stroke 37:2170-2173, Janzarik,W.G.,et al, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Persistent Infarct Hyperintensity on Diffusion-Weighted Imaging Late After Stroke Indicates Heterogeneous, Delayed, Infarct Evolution
Stroke 37:1418-1423, Rivers,C.S.,et al, 2006
Community Socioeconomic Status and Prehospital Times in Acute Stroke and Transient Ischemic Attack
Stroke 37:1508-1513,1354, Kleindorfer,D.O.,et al, 2006
Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke. A Systematic Review.
Stroke 37:1334-1339, Bandera,E.,et al, 2006
Corticosteroids in Patients With Hemorrhagic Stroke
Stroke 37:1344-1345, Feigin,V.L.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
Does the Merci Retriever Work? For.
Stroke 37:1340-1341, Saver,J.L., 2006
Does the Merci Retriever Work? Against.
Stroke 37:1341-1342, Wechsler,L.R., 2006
Perceptual, Social, and Behavioral Factors Associated With Delays in Seeing Medical Care in Patients With Symptoms of Acute Stroke
Stroke 37:1248-1253, Mandelzweig,L.,et al, 2006
Long-Term Mortality After Intracerebral Hemorrhage
Neurol 66:1182-1186, Flaherty,M.I.,et al, 2006
Hematoma Growth is a Determinant of Mortality and Poor Outcome After Intracerebral Hemorrhage
Neurol 66:1175-1181, Davis,S.M.,et al, 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
The Insular Cortex and Cardiac Response to Stroke
Neurol 66:1296-1297, Cheshire,W.P. Jr., &Saper,C.B., 2006
Predictors of Hemorrhage in Patients with Untreated Brain Arteriovenous Malformation
Neurol 66:1350-1355, Stapf,C.,et al, 2006
Elevated Troponin Levels are Associated with Higher Mortality Following Intracerebral Hemorrhage
Neurol 66:1330-1334, Hays,A. &Diringer,M.N., 2006
The Influence of Estrogen on Migraine
JAMA 295:1824-1830, Brandes,J.L., 2006
Prospective Study of Symptomatic Atherothrombotic Intracranial Stenoses. The GESICA Study
Neurol 66:1187-1191, Mazighi,M.,et al, 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Clinical Outcome After First and Recurrent Hemorrhage in Patients With Untreated Brain Arteriovenous Malformation
Stroke 37:1243-1247, Choi,J.H.,et al, 2006
ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006
Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006